Early detection of heart attacks and strokes, before it's too late. (e.g. in time to treat medically instead of waiting until a surgical intervention is your only option).

CardioRisk Laboratories is a national service company offering Carotid Intima Media Thickness (CIMT) screening to primary care physicians, cardiologists, and other health care professionals and patients to help them identify and reduce cardiac, and cerebrovascular events in their patients. A CIMT test provides patients with an assessment of their individual risk for heart attack, stroke, and other ischemic events.

CardioRisk provides this valuable assessment of heart attack and stroke risk at physician offices throughout the United States. We support pharmaceutical, clinical outcome, and epidemiologic studies where CIMT is used to monitor disease progression or as a surrogate for clinical events.

In a 10-year, 100,000 person-year longitudinal study, IMT technology caught 98.6% of the heart attacks and strokes BEFORE they occurred.  That is better than a home pregnancy test.  The CardioRisk CIMT exam was scientifically designed, validated via peer-reviewed published literature demonstrating CardioRisk's unique protocol which specializes in reproducibility, sensitivity, and specificity for heart disease.  The test in non-invasive, requires no radiation exposure, no disrobing is necessary and there are no needle sticks or any pain involved.  Call CardioRisk to arrange to be tested in your area.

Health Care

Cardiorisk Laboratories

Cardiorisk Laboratories' headquarters in United States

Description

People (1)

Todd Eldredge

Jobs